Display options
Share it on

Neth Heart J. 2013 Dec;21(12):540-4. doi: 10.1007/s12471-013-0471-2.

What do cardiologists know about the effects of cardiovascular agents on sexual function? A survey among Dutch cardiologists. Part I.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

M P J Nicolai, S S Liem, S Both, R C M Pelger, H Putter, M J Schalij, H W Elzevier

Affiliations

  1. Department of Urology, Leiden University Medical Center, PO box 9600, 2300, RC, Leiden, the Netherlands, [email protected].

PMID: 24072687 PMCID: PMC3833914 DOI: 10.1007/s12471-013-0471-2

Abstract

INTRODUCTION: Several cardiovascular agents, such as diuretics and β-blockers, can negatively affect sexual function, leading to noncompliance with therapy. Others such as angiotensin II receptor blockers (ARBs) can improve patients' sexual function.

AIMS: We aimed to gain insight into cardiologists' knowledge about the effects of cardiovascular drugs on sexual function and whether they take this knowledge into account when prescribing drugs.

METHODS: An anonymous questionnaire was mailed to 980 members of the Netherlands Society of Cardiologists (cardiologists and residents in training).

RESULTS: Almost 54 % of Dutch cardiologists responded; 414 questionnaires were analysed. Forty-five percent of cardiologists were aware that diuretics can negatively affect sexual function, 93.1 % knew about the negative effects β-blockers can have, but only 9.2 % were aware that ARBs can have positive effects on sexual health. Almost half of respondents (48.2 %) stated they change medication regularly in an attempt to improve sexual function. Experienced cardiologists said they do this significantly more often than less experienced ones.

CONCLUSIONS: Cardiologists' knowledge about the effects of cardiovascular drugs on sexual health appears to be insufficient. Sexual dysfunction is not routinely taken into account when cardiologists prescribe drugs.

References

  1. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Nov-Dec;16(6):460-7 - PubMed
  2. J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):424-32 - PubMed
  3. BJU Int. 2011 Dec;108(11):1850-4 - PubMed
  4. J Hypertens. 2006 Dec;24(12):2387-92 - PubMed
  5. Drugs. 2005;65(6):773-86 - PubMed
  6. Adv Data. 2007 Jun 29;(387):1-39 - PubMed
  7. Circulation. 2012 Feb 28;125(8):1058-72 - PubMed
  8. J Am Coll Cardiol. 2011 Sep 20;58(13):1378-85 - PubMed
  9. Am Heart J. 2012 Feb;163(2):246-51 - PubMed
  10. Int J Impot Res. 2012 Nov-Dec;24(6):217-20 - PubMed
  11. Clin Res Cardiol. 2013 May;102(5):329-36 - PubMed
  12. N Engl J Med. 1986 Jun 26;314(26):1657-64 - PubMed
  13. J Androl. 2006 Nov-Dec;27(6):795-801 - PubMed
  14. Int J Clin Pract. 2011 Mar;65(3):289-98 - PubMed
  15. Am J Hypertens. 2004 Jan;17(1):77-81 - PubMed
  16. Clin Exp Pharmacol Physiol. 2007 Apr;34(4):327-31 - PubMed
  17. J Hypertens. 2012 Jan;30(1):210-6 - PubMed
  18. Blood Press Suppl. 2003 Dec;2:29-34 - PubMed
  19. J Sex Med. 2008 Aug;5(8):1841-65 - PubMed
  20. Int J Impot Res. 2008 Sep-Oct;20(5):493-500 - PubMed
  21. Eur J Clin Pharmacol. 2002 Jun;58(3):177-80 - PubMed
  22. J Urol. 2000 Oct;164(4):1188-91 - PubMed
  23. Ann Intern Med. 1991 Apr 15;114(8):613-20 - PubMed
  24. Curr Hypertens Rep. 2012 Aug;14(4):285-92 - PubMed
  25. Urology. 1997 Jun;49(6):822-30 - PubMed

Publication Types